'There's no straight line…' a consumer-informed intervention for FTD family care partners: the STELLA-FTD pilot study.
Allison Lindauer, Samantha Smith, Sarah Gothard...
https://pubmed.ncbi.nlm.nih.gov/37655616/Actively Recruiting
Led by Oregon Health and Science University · Updated on 2025-10-27
640
Participants Needed
1
Research Sites
N/A
Total Duration
Researchers are evaluating STELLA-FTD, a videoconference-based program designed to support family Care Partners of people with frontotemporal degeneration FTD. This nationwide study focuses on helping Care Partners manage behavioral and psychological symptoms of dementia by improving use of community and peer resources. The study will include up to 320 Care Partners and their 320 Care Recipients with FTD from across the United States. The intervention consists of 8 live video group sessions held over 10 consecutive weeks, each lasting one hour and led by two guides. Participants will be randomly assigned to either a test group or a control group. Both groups receive information and support through videoconferencing, but the test group follows a different program. Groups include up to 8 Care Partners to encourage trust and commitment. Care Recipients will not participate in the intervention but will be consented to allow data collection. During the study, Care Partners will complete six detailed surveys and weekly brief surveys to monitor progress and outcomes. Researchers will assess changes in behavioral symptoms using the Revised Memory and Behavior Problems Checklist at several points before, during, and after the intervention. Secondary measures include caregiver self-efficacy, preparedness, support use, and experience surveys. The total participation spans from one month before intervention through six months post-intervention, with ongoing weekly monitoring until week 36.
CONDITIONS
STELLA-FTD: Examination of a Behavior Change Intervention for FTD Family Care Partners
H
Hailey Chatterton, MS
A
Allison Lindauer, PhD, APRN
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Oregon Health and Science University
Lead Sponsor
National Institute on Aging (NIA)
Collaborating Sponsor
This table compares participation in this trial with other options available for this condition. The information is drawn from published research and the trial’s study details and is provided for educational purposes only.
| Factors | STELLA‑FTD Behavior Change | Active Video‑Group Support |
|---|---|---|
| What it is | Eight weekly live group videoconference sessions led by guides teaching a structured behavioral management program for family care partners of people with FTD. | Eight weekly live group videoconference sessions led by guides delivering informational and peer support content for family care partners. |
| Role in the trial | Investigational behavioral change arm designed to reduce caregiver burden by teaching behavioral management techniques. | Active comparator providing general information and peer support without the structured behavioral focus. |
| Primary use or goal | To teach care partners behavior‑changing strategies to manage frustrating behaviors in individuals with FTD. | To provide general information and peer support to care partners managing FTD-related behaviors. |
| How it is given or performed | Delivered in small groups of up to 8 care partners, via one‑hour live videoconference sessions over approximately 10 weeks. | Delivered in small groups of up to 8 care partners, via one‑hour live videoconference sessions over approximately 10 weeks. |
| Evidence status | Effectiveness not yet established; this is an early‑stage randomized behavioral trial. | Effectiveness compared only to the investigational arm; this arm serves as active support without proven behavior‑management components. |
| Important limitations | Behavior change focus may not suit all care partners’ needs; small group sessions require video‑conferencing access and scheduling consistency. | Provides general support but lacks structured behavioral techniques that may be key to reducing distress. |
Disclaimer: This comparison is created with the help of artificial intelligence(AI) and may contain errors or missing information. It is not medical advice and does not mean one option is better or safer than another. Clinical trials are still being studied, and joining a trial is your choice. Please consult your healthcare professional before making any decisions.
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person or virtual) for eligibility assessment
Duration - 10 consecutive weeks
Care Partners participate in 8 weekly 1-hour live video-based group sessions focused on behavior change and support. Participants are randomized to either the test or control group, both receiving group support but with different program content.
Weekly video group sessions for 8 weeks
Duration - Up to 6 months post-intervention
Participants complete surveys and assessments over several months to evaluate the impact of the intervention, including brief weekly surveys and periodic questionnaires up to 6 months after intervention ends.
Weekly brief surveys up to 36 weeks; additional assessments at 2 and 6 months post-intervention
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Have more questions? Get in touch with our team for quick support
Allison Lindauer, Samantha Smith, Sarah Gothard...
https://pubmed.ncbi.nlm.nih.gov/37655616/Oregon Health and Science University
Lead Sponsor
National Institute on Aging (NIA)
Collaborating Sponsor